Long Ideas - The Centers for Medicare and Medicaid Services (CMS) publicized a regulatory proposal on Thursday that cuts reimbursement payments for in-home health service providers by 3.5% … Continue Reading
Read nowMost Popular - A study published yesterday in PLOS Biology offers a damning assessment of recent IPO PTC Therapeutics’ (PTCT) lead candidate ataluren. PTC began trading on the Nasdaq last … Continue Reading
Read nowMost Popular - Isis Pharmaceuticals (ISIS) revealed impressive numbers from its Phase II trial of ISIS-APOCIIIRx in patients with high triglycerides and type 2 diabetes yesterday at the American Diabetes Association … Continue Reading
Read nowLong Ideas - Amarin (AMRN) announced Friday morning that a Phase I trial comparing the bioavailability of components from a fixed-dose combination of Vascepa plus rosuvastatin, to concomitant … Continue Reading
Read nowLong Ideas - Synergy Pharmaceuticals (SGYP) is well-funded, with over $100 million in cash after its last capital raise, and the weakening biotech tape of late enables investors … Continue Reading
Read nowLong Ideas - Large-cap drug company Eli-Lilly (LLY) must have liked what it saw in April when Transition Therapeutics (TTHI) reported its Phase Ib proof-of-concept results for TT-401, … Continue Reading
Read nowShort Ideas - Intercept Pharmaceuticals (ICPT) on Monday morning announced the sale of 1.73 million shares of common stock (2 million with underwriter’s over-allotment) in a deal that … Continue Reading
Read now